65 related articles for article (PubMed ID: 20236710)
1. The antibody response to oligodendrocyte specific protein in multiple sclerosis.
Aslam M; Kalluri SR; Cepok S; Kraus V; Buck D; Srivastava R; Hemmer B
J Neuroimmunol; 2010 Apr; 221(1-2):81-6. PubMed ID: 20236710
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve.
Bajramovic JJ; Brok HP; Ouwerling B; Jagessar SA; van Straalen L; Kondova I; Bauer J; Amor S; 't Hart BA; Ben-Nun A
Eur J Immunol; 2008 May; 38(5):1452-64. PubMed ID: 18412169
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice.
Stevens DB; Chen K; Seitz RS; Sercarz EE; Bronstein JM
J Immunol; 1999 Jun; 162(12):7501-9. PubMed ID: 10358205
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid immunoglobulin G promotes oligodendrocyte progenitor cell migration.
Tiwari-Woodruff SK; Myers LW; Bronstein JM
J Neurosci Res; 2004 Aug; 77(3):363-6. PubMed ID: 15248292
[TBL] [Abstract][Full Text] [Related]
5. A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic.
Bronstein JM; Lallone RL; Seitz RS; Ellison GW; Myers LW
Neurology; 1999 Jul; 53(1):154-61. PubMed ID: 10408552
[TBL] [Abstract][Full Text] [Related]
6. [The study of anti-oligodendrocyte antibody in sera, and CSF of patients with multiple sclerosis].
Hirayama M; Kawai K; Iida M
Rinsho Shinkeigaku; 1990 Mar; 30(3):262-5. PubMed ID: 2364627
[TBL] [Abstract][Full Text] [Related]
7. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
[TBL] [Abstract][Full Text] [Related]
8. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
Lily O; Palace J; Vincent A
Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
[TBL] [Abstract][Full Text] [Related]
9. OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207.
Kaushansky N; Hemo R; Eisenstein M; Ben-Nun A
Eur J Immunol; 2007 Jul; 37(7):2018-31. PubMed ID: 17549734
[TBL] [Abstract][Full Text] [Related]
10. T-cell responses to oligodendrocyte-specific protein in multiple sclerosis.
Vu T; Myers LW; Ellison GW; Mendoza F; Bronstein JM
J Neurosci Res; 2001 Nov; 66(3):506-9. PubMed ID: 11746369
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.
Archelos JJ; Trotter J; Previtali S; Weissbrich B; Toyka KV; Hartung HP
Ann Neurol; 1998 Jan; 43(1):15-24. PubMed ID: 9450764
[TBL] [Abstract][Full Text] [Related]
12. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
13. Anti-heat shock protein 90beta antibodies are detected in patients with multiple sclerosis during remission.
Cid C; Regidor I; Alcázar A
J Neuroimmunol; 2007 Mar; 184(1-2):223-6. PubMed ID: 17161872
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
15. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P
J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688
[TBL] [Abstract][Full Text] [Related]
16. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
17. Interferon inhibitory activity in patients with multiple sclerosis.
Chadha K; Weinstock-Guttman B; Zivadinov R; Bhasi K; Muhitch J; Feichter J; Tamaño-Blanco M; Abdelrahman N; Ambrus J; Munschauer F; Ramanathan M
Arch Neurol; 2006 Nov; 63(11):1579-84. PubMed ID: 17101826
[TBL] [Abstract][Full Text] [Related]
18. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
Garg N; Zivadinov R; Ramanathan M; Vasiliu I; Locke J; Watts K; Lema J; Rajeswary J; Munschauer FE; Ambrus J; Weinstock-Guttman B
J Neuroimmunol; 2007 Jul; 187(1-2):159-65. PubMed ID: 17512610
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
Menge T; Lalive PH; von Büdingen HC; Cree B; Hauser SL; Genain CP
J Allergy Clin Immunol; 2005 Aug; 116(2):453-9. PubMed ID: 16083805
[TBL] [Abstract][Full Text] [Related]
20. Oligoclonal bands and antibody responses in multiple sclerosis.
Correale J; de los Milagros Bassani Molinas M
J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
